Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia.
Ohyashiki
Kazuma
K
Hematology Division, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 169-0023, Japan. ohyashik@rr.iij4u.or.jp.
Kiguchi
Toru
T
Hematology Division, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 169-0023, Japan.
Ito
Yoshikazu
Y
Hematology Division, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 169-0023, Japan.
Fujimoto
Hiroaki
H
Hematology Division, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 169-0023, Japan.
Gotoh
Akihiko
A
Hematology Division, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 169-0023, Japan.
Tauchi
Tetsuzo
T
Hematology Division, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 169-0023, Japan.
Miyazawa
Keisuke
K
Hematology Division, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 169-0023, Japan.
Kimura
Yukihiko
Y
Hematology Division, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 169-0023, Japan.
Ohyashiki
Junko H
JH
Intractable Immune System Diseases Research Center, Tokyo Medical University, Tokyo, Japan.
D000368:Aged; D005260:Female; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics / Q000378:metabolism*; D007964:Leukocytosis / Q000150:complications / Q000175:diagnosis* / Q000201:enzymology* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D010649:Phenylalanine / Q000235:genetics / Q000378:metabolism; D013920:Thrombocythemia, Essential / Q000150:complications* / Q000201:enzymology* / Q000235:genetics; D013927:Thrombosis / Q000150:complications / Q000175:diagnosis* / Q000201:enzymology* / Q000235:genetics; D014633:Valine / Q000235:genetics / Q000378:metabolism
D010649:Phenylalanine; D053614:Janus Kinase 2; D014633:Valine